CamOncology Leadership
Bill Robinson (Non Exec Chairman)
Bill Robinson (Non Exec Chairman)
Bill Robinson (Non Exec Chairman)
Bill Robinson. Formerly COO of UCB, a Brussels-based global biopharmaceutical company. 35 years at Eli Lilly, one of the leading US pharmaceutical companies, where he held a number of senior international management roles in Sales and Marketing, General Management, and Research and Development. Prior to his retiring from Lilly he was VP for US Sales and Marketing
James Harrison (Director)
Bill Robinson (Non Exec Chairman)
Bill Robinson (Non Exec Chairman)
Founder and Group CEO of Cycle Group Holdings Ltd, which includes Cycle Pharmaceuticals – a $50m net sales rare disease pharmaceutical business a clinical-stage oncology biotech that has licensed projects from University of Cambridge and Harvard Medical School.
Former MD of TowerBrook Capital Partners and Partner of Soros Fund Management.
David Buckeridge (Director)
Bill Robinson (Non Exec Chairman)
David Buckeridge (Director)
David has over 35 years of operational management experience in the life science and agribusiness industries.
Group CEO of Advanta BV, the largest independent agronomic seed business in the world at that time.
Former Partner of Paine Schwartz, a food chain focussed private equity business.
20 years at AZ in a variety of management positions globally.